Articles On Oncosil Medical (ASX:OSL)

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

22 Jan 2021 - Medical device company, OncoSil Medical (ASX:OSL) has appointed Nigel Lange as Chief Executive Officer and Managing Director.

The Oncosil Medical Ltd (ASX: OSL) share price jumped 10% on Thursday after the company received regulatory clearance to market and sell its products in Switzerland.  About Oncosil  Oncosil is focused on localised treatments for patients w...

The coronavirus pandemic has rocked almost every economy around the world, and Australia's is no exception. Although Australia has done a relatively decent job containing the spread of the virus when compared to other countries, it hasn’t b...

ShareCafeOncosil Medical – ShareCafe Hidden Gems Webinar Presentation   Presenter – Daniel Kenny – CEO – OncoSil Medical is a medical device company seeking to advance radiation for cancer patients. OncoSil Medical’s lead product, OncoSilT...

ShareCafeHidden Gems Webinar Recap – OSL, MDC, CYP, GSS   We continue to unearth small-cap companies as part of our Hidden Gems webinar series. Catch up on the full webinar with presentations from Oncosil Medical (ASX:OSL), Medlab Clinical...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The pundit...

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the pen and picking up the microphone for another instalment of The Health Kick Podcast. In this episode Tim catches up with Daniel Kenny, Chief Executive Officer at...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Now invest...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

OncoSil Medical (ASX:OSL) has received CE Mark approval to market and sell its breakthrough implantable radiotherapy treatment for pancreatic cancer in the EU and UK.

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   This week’s big themes The ca...

Medical device company OncoSil Medical (ASX: OSL) has announced that it has finally received the CE Mark from the British Standards Institute (BSI) for its proprietary OncoSil device – a means of treating locally advanced pancreatic cancer...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

OncoSil Medical Ltd (ASX:OSL) has received CE Marking approval from the British Standards Institute (BSI) for its OncoSilTM device used in the treatment of locally advanced pancreatic cancer (LAPC) in combination with chemotherapy. OncoSilT...

OncoSil Medical Ltd (ASX:OSL) has received CE Marking approval from the British Standards Institute (BSI) for its OncoSilTM device used in the treatment of locally advanced pancreatic cancer (LAPC) in combination with chemotherapy. OncoSilT...

Medical device company OncoSil Medical (ASX: OSL) has been granted what’s known as breakthrough device designation by the US Food and Drug Administration (FDA) for the treatment of pancreatic cancer in combination with systemic chemotherapy...

Medical device company OncoSil Medical (ASX: OSL) has been granted what’s known as breakthrough device designation by the US Food and Drug Administration (FDA) for the treatment of pancreatic cancer in combination with systemic chemotherapy...

OncoSil Medical Ltd (ASX:OSL) today announced that the OncoSilTM device has reached a significant milestone, receiving Breakthrough Device Designation by the US Food and Drug Administration (FDA) for the treatment of unresectable locally ad...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

OncoSil Medical (ASX: OSL) has developed a first-in-class, truly innovative device that treats unresectable locally advanced pancreatic cancer — that is, tumours that can’t be surgically removed.

The health sector was the most successful sector on the ASX in 2019. Various small caps made several breakthroughs including with nerve damage and macular degeneration. While cancer remains one fish that has yet to be fried there are small...

The coming 12 months is shaping up as a watershed stage in the history of Oncosil Medical Ltd (ASX:OSL) with the company having flagged finalisation of commercialisation plans for its OncoSilTM device in anticipation of CE Marking early in...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Medical devices are considered as an essential part of the health care industry and range from a bandage to high-risk products for implanting in the human body such as pacemakers. Medical devices differ from the general medicines as they ar...

Medical device company, OncoSil Medical Ltd (ASX: OSL) has provided updated on its CE Marking review after a meeting with BSI Management. Post Market Surveillance (PMS) Plan and Post Market Clinical Follow-up (PMCF) programme were discusse...

In this article we are discussing five ASX-listed health care stocks, Althea Group Holdings Limited (ASX: AGH), Botanix Pharmaceuticals Limited (ASX:BOT), SDI Limited (ASX: SDI), Mach7 Technologies Limited (ASX: M7T), OncoSil Medical Limite...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Health care sector is one of the popular sectors among investors, as it is one of the high yielding sectors. However, at times, investors also lose their money, when health care stocks engaged in research & development activities fail t...

The notion of ‘everything old is new again’ applies not just to fickle fashion trends, but to drug development as well. Drug reformulations are all the rage and it’s not such a bad thing. Think of Paradigm Biopharmaceuticals (ASX:PAR) with...

The science of Regenerative Medicine is a rapidly emerging field linking the medical technology, biotechnology and pharmaceutical sectors, and holds much potential to deliver better patient outcomes and drive economic growth.  Regenerative...

Zelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in th...

Since the ASX is flooded with quarterlies, we’ve summarised a list of the five health companies that got the biggest share-price boost in morning trade due to 4C releases: Oncosil Medical (ASX: OSL) As Oncosil is at the research and develop...

In this week’s recap of substantial holder movements four substantial holders bought shares in Zenith Energy (ASX:ZEN), a Shanghai investor bought into Anson Resources (ASX:ASN) and Sirtex’s founder bought into Syrah Resources (ASX:SYR). Su...